Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Treatment of SARS Caused by COVID-19 With Ruxolitinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
COVID-19 in Patients With HIV
- Status
- COMPLETED
- Phase
- N/A
Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study
- Status
- UNKNOWN
- Phase
- N/A
Chloroquine for Mild Symptomatic and Asymptomatic COVID-19
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
- Status
- UNKNOWN
- Phase
- NA
Application of Desferal to Treat COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Piclidenoson for Treatment of COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
- Status
- TERMINATED
- Phase
- NA
Safety in Convalescent Plasma Transfusion to COVID-19
- Status
- TERMINATED
- Phase
- PHASE1
Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers
- Status
- COMPLETED
- Phase
- PHASE2
Azithromycin for COVID-19 Treatment in Outpatients Nationwide
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)
- Status
- UNKNOWN
- Phase
- PHASE2
Hyperbaric Oxygen for COVID-19 Patients
- Status
- TERMINATED
- Phase
- NA
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study of Patients With Coronavirus Disease 2019
- Status
- COMPLETED
- Phase
- N/A
Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic
- Status
- COMPLETED
- Phase
- PHASE3
Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia
- Status
- TERMINATED
- Phase
- NA
Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2